Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D. L. Reidy
Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients
Clinical Cancer Research
Cancer Research
Oncology
Related publications
BRAF-mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade With Dabrafenib, Trametinib, and Panitumumab in Patients With Colorectal Cancer
Clinical Cancer Research
Cancer Research
Oncology
Prevalence of KRAS, BRAF, PI3K and EGFR Mutations Among Asian Patients With Metastatic Colorectal Cancer
Oncology Letters
Cancer Research
Oncology
RAS and BRAF in Metastatic Colorectal Cancer Management
Journal of Gastrointestinal Oncology
Oncology
Gastroenterology
BRAF Mutant Colorectal Cancer: ErbB2 Expression Levels as Predictive Factor for the Response to Combined BRAF/ErbB Inhibitors
BMC Cancer
Cancer Research
Oncology
Genetics
BRAF-mutated Metastatic Colorectal Cancer Between Past and Future
British Journal of Cancer
Cancer Research
Oncology
BRAF V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression
Clinical Cancer Research
Cancer Research
Oncology
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma
Frontiers in Oncology
Cancer Research
Oncology
Acquired Resistance to BRAF Inhibition Can Confer Cross-Resistance to Combined BRAF/MEK Inhibition
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Clinical Responses to ERK Inhibition in BRAF V600e-Mutant Colorectal Cancer Predicted Using a Computational Model
npj Systems Biology and Applications
Genetics
Molecular Biology
Biochemistry
Applied Mathematics
Simulation
Computer Science Applications
Modeling
Drug Discovery
